NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma
Sibo Zhao(Baylor College of Medicine), Jason T. Yustein(Emory University), Davis R. Ingram(The University of Texas MD Anderson Cancer Center), John Hicks(Baylor College of Medicine), Alison Roos(Mayo Clinic in Arizona), Chad J. Creighton(Baylor College of Medicine), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Dina Lev(Assuta Medical Center), Ching C. Lau(University of Hong Kong), Ying Gao(Harbin Medical University), Anthony M.C. Brown(Cornell University), Lawrence A. Donehower(Baylor College of Medicine), Lyazat Kurenbekova(Baylor College of Medicine), Pulivarthi H. Rao(Baylor College of Medicine), Stephen N. Jones(Villanova University)
Cited by 150
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k